Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Plos One|February 15, 2013
Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myelomaDeepti Soodgupta, Michelle A Hurchla, Majiong Jiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptideJennifer E Sprague, Hideki Kitaura, Wei Zou, et al.
Molecular Imaging and Biology|August 20, 2011
Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulationAlexander Zheleznyak, Thaddeus J Wadas, Christopher D Sherman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2012
Breast cancer cell targeting by prenylation inhibitors elucidated in living animals with a bioluminescence reporterSharon L Chinault, Julie L Prior, Kevin M Kaltenbronn, et al.
Cancer Research|March 12, 2009
CD47 regulates bone mass and tumor metastasis to boneOzge Uluçkan, Stephanie N Becker, Hongju Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2007
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in boneAngela C Hirbe, Jessica Rubin, Ozge Uluçkan, et al.
Molecular Cancer Research : MCR|February 7, 2013
Role of WNT7B-induced noncanonical pathway in advanced prostate cancerDali Zheng, Keith F Decker, Tianhua Zhou, et al.
American Journal of Clinical Pathology|December 11, 2002
Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparationsMatthew V Sheffield, Herman Yee, Christine C Dorvault, et al.
Molecular Carcinogenesis|October 11, 2023
Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cellsErin R Scheidemann, Diane M Demas, Chunyan Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patientsMark A Watson, Lourdes R Ylagan, Kathryn M Trinkaus, et al.
Pageof 7